Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease
Elizabeth Spencer, Suzannah Bergstein, Michael Dolinger, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 11, pp. 2057-2063
Closed Access | Times Cited: 16

Showing 16 citing articles:

Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience
Guo Cheng, Jin Zhou, Guoli Wang, et al.
Children (2025) Vol. 12, Iss. 1, pp. 75-75
Open Access
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
Shlomi Cohen, Elizabeth Spencer, Michael Dolinger, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access
Positionspapier der Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) zum zulassungsüberschreitenden Gebrauch von für Erwachsene mit CED zugelassenen Biologika und Signalinhibitoren bei Kindern und Jugendlichen
Jan Däbritz, Martin Claßen, K. Krohn, et al.
Zeitschrift für Gastroenterologie (2025)
Open Access
Observation of the efficacy of upadacitinib as salvage therapy for refractory pediatric inflammatory bowel disease
Tian-Lu Mei, Yi Wang, Chunna Zhao, et al.
Journal of Pediatric Gastroenterology and Nutrition (2025)
Closed Access
Reply: Opioids Intertwined With Psychology: Hidden Effects in the Treatment of Patients With IBD
Christy Riggott, Keeley M. Fairbrass, Christian P. Selinger, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease
Amelia Kellar, Michael Dolinger, Elizabeth Spencer, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 5, pp. 1826-1833
Closed Access | Times Cited: 4
Therapeutic Inhibition of the JAK-STAT pathway in the treatment of Inflammatory Bowel Disease.
Zihan Chen, Ping Jiang, Dan Su, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 1-15
Closed Access | Times Cited: 4
Upadacitinib is associated with clinical response and steroid‐free remission for children and adolescents with inflammatory bowel disease
Joseph Runde, Kelsey Ryan, Joseph B. Hirst, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Closed Access | Times Cited: 2
Advancements in the management of pediatric inflammatory bowel disease
Jonathan O'Donnell, Sonia Thomas, Eric I. Benchimol
Expert Review of Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 1
Upadacitinib as salvage therapy in adolescents with acute severe ulcerative colitis refractory to conventional treatments
Andrew Dickerson, Jeannie S. Huang, Laura Bauman
JPGN Reports (2024) Vol. 5, Iss. 4, pp. 447-453
Open Access | Times Cited: 1
The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease
Meryem T. Ok, Paul B. Googe, Christopher Sayed, et al.
Pediatric Dermatology (2024)
Closed Access
Considerations in Paediatric and Adolescent Inflammatory Bowel Disease
S Vuijk, A Camman, Lissy de Ridder
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. Supplement_2, pp. ii31-ii45
Open Access
Updates In The Management Of Pediatric Inflammatory Bowel Disease
Nicholas Carman
Canadian IBD Today (2024)
Open Access
Rapid Remission with Upadacitinib in a Child with Refractory Crohn's Disease and ATM Mutation: A Case Report
Yan Liu, Xiaomei Song, Lingya Xiang, et al.
Current Therapeutic Research (2024) Vol. 101, pp. 100756-100756
Open Access
Evaluating the significance of ECSCR in the diagnosis of ulcerative colitis and drug efficacy assessment
Bin Feng, Yanqiu Zhang, Longwei Qiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Use of upadacitinib in a child with refractory ulcerative colitis
А. С. Потапов, A. E. Pushkareva, A.V. Vinokurova, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 13, pp. 124-129
Open Access
Page 1

Scroll to top